Shandong Chuangye Pharmaceutical Technology Co., Ltd., established in April 2019 with a registered capital of 3 million, is specialized in R & D and technology development services of impurity reference materials, pharmaceutical intermediates and APIs. The R & D team of the company brings together a group of outstanding industry elites, with 12 full-time synthesis researchers, rich experience in pharmaceutical R & D, fully equipped with the technical strength of developing various chemicals, and has its own unique advantages in product development, pilot production and process optimization. At the same time, the company has established deep cooperation with Shenzhen Institute of advanced technology of Chinese Academy of Sciences and the Application Institute of Guizhou University.

The company's existing advantageous products:  Dominant pharmaceutical intermediates, trogliptin succinate and its intermediates, tedezolamine phosphate and its intermediates, agliptin benzoate and its intermediates, etc. the products meet the Pharmacopoeia standards and have sufficient inventory to provide customers with the best quality products and the most reasonable prices.

Adhering to the spirit of customer first and pursuing excellence, we continue to expand the capabilities of enterprises in all aspects, provide more high-quality products and services for customers at home and abroad, meet the increasing needs of customers, and contribute to the fight against diseases.